Overview
The goal of this trial is to learn about the safety of MK-1167 and if people tolerate it.
Eligibility
The key inclusion criteria but are not limited to the following:
- Is in good health
- Has a body mass index (BMI) ≥18 and ≤32 kg/m\^2, inclusive
The key inclusion criteria but are not limited to the following:
- Has a history of clinically significant endocrine, gastrointestinal, cardiovascular, hematological, hepatic, immunological, renal, respiratory, genitourinary, or major neurological abnormalities or diseases
- Is a smoker and/or has used nicotine or nicotine-containing products (for example, nicotine patch and electronic cigarette) within the past 3 months